Quest Diagnostics

NYSE: DGX · Real-Time Price · USD
178.44
-0.60 (-0.34%)
At close: Aug 14, 2025, 3:59 PM
179.50
0.59%
Pre-market: Aug 15, 2025, 07:01 AM EDT

Quest Diagnostics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
9.87B 9.25B 9.88B 10.79B
Cost of Revenue
6.63B 6.2B 6.45B 6.58B
Gross Profit
3.24B 3.07B 3.43B 4.21B
Operating Income
1.35B 1.26B 1.43B 2.38B
Interest Income
25M 11M 10M 1M
Pretax Income
1.19B 1.16B 1.28B 2.68B
Net Income
871M 854M 946M 2B
Selling & General & Admin
1.77B 1.61B 1.87B 1.73B
Research & Development
n/a n/a n/a n/a
Other Expenses
128M 192M 131M 101M
Operating Expenses
1.9B 1.81B 2B 1.83B
Interest Expense
226M 163M 148M 152M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
8.53B 7.99B 8.46B 8.41B
Income Tax Expense
273M 248M 264M 597M
Shares Outstanding (Basic)
111M 112M 116M 125M
Shares Outstanding (Diluted)
113M 113M 118M 128M
EPS (Basic)
7.80 7.59 8.12 15.90
EPS (Diluted)
7.69 7.52 7.98 15.53
EBITDA
1.89B 1.73B 1.82B 3.16B
EBIT
1.4B 1.29B 1.38B 2.75B
Depreciation & Amortization
493M 439M 437M 408M